Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative transcriptomic analysis of peripheral blood identifies NETosis-associated programs and a stratified adaptive immune suppression pattern in severe acute pancreatitis. | PLoS One | 2026 | 42789536 | PubTator, text mining | PubMed |
| Growth Differentiation Factor 15 as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis. | Ann Neurol | 2026 | 42770667 | PubTator, text mining | PubMed |
| Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity. | FASEB J | 2026 | 42622615 | PubTator, text mining | PubMed |
| Single-Cell Profiling Identifies the SPDEF/GAS5 Axis as a Potential Driver of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer. | Cureus | 2026 | 42528776 | PubTator, text mining | PubMed |
| Protein glycosylation profiling in lung adenocarcinoma and precursor lesions: analysis of FFPE tissue sections. | Anal Bioanal Chem | 2026 | 42509285 | PubTator, text mining | PubMed |
| Clinical and molecular correlates of digitally quantified anthracosis in lung tissue slides: utility of an automated quantitative workflow. | J Pathol Clin Res | 2026 | 42473194 | PubTator, text mining | PubMed |
| Corrigendum to: "A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth" [Cancer Lett. 648, (2026) 218463]. | Cancer Lett | 2026 | 42469116 | PubTator, text mining | PubMed |
| Normalized internalization predicts potency of carcinoembryonic antigen-related cell adhesion molecule 6-targeting antibody-drug conjugates. | J Control Release | 2026 | 42309467 | PubTator, text mining | PubMed |
| Targeting Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: Rationale, Current Evidence, and a CEACAM6 CAR-T Strategy. | Cancers (Basel) | 2026 | 42279434 | PubTator, text mining | PubMed |
| SLC22A4 as a candidate regulator linking immunity and ferroptosis in septic shock. | Mol Immunol | 2026 | 42275906 | PubTator, text mining | PubMed |
| C4BP occludes the non-opsonic interaction of Neisseria gonorrhoeae with human neutrophil CEACAMs. | Infect Immun | 2026 | 42267928 | PubTator, text mining | PubMed |
| CSF-Seq enables transcriptome-wide profiling of cerebrospinal fluid and identifies prognostic signature of leptomeningeal disease. | bioRxiv | 2026 | 42244707 | PubTator, text mining | PubMed |
| Structural basis for asymmetric bis-intercalator targeting of DNA triplex junctions enabling dual inhibition of topoisomerase I and oncogene transcription. | Nucleic Acids Res | 2026 | 42206361 | PubTator, text mining | PubMed |
| Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity. | bioRxiv | 2026 | 42182462 | PubTator, text mining | PubMed |
| [Modality strategy in Eisai drug discovery: challenges toward next-generation therapeutics using proximity-inducing compound]. | Nihon Yakurigaku Zasshi | 2026 | 42091470 | PubTator, text mining | PubMed |
| Olfactomedin 4 orchestrates TGF-β/CEACAM6 axis, promoting cell-autonomous epithelial to mesenchymal transition during gallbladder epithelium carcinogenesis. | Oncogene | 2026 | 42050078 | PubTator, text mining | PubMed |
| Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells. | Nature | 2026 | 42020746 | PubTator, text mining | PubMed |
| Pre- and postoperative expression of circulating CEACAM1 and CEACAM6 using a nanoparticle-supported, lectin-specific assay detected in serum from patients with colorectal cancer. | Scand J Gastroenterol | 2026 | 42017600 | PubTator, text mining | PubMed |
| Serum CEACAM6 and CEACAM8 as predictors of poor outcome in pediatric Mycoplasma pneumoniae pneumonia: A single-center prospective cohort study. | Medicine (Baltimore) | 2026 | 41961692 | PubTator, text mining | PubMed |
| Activation of ERBB4 Pathway Inhibits Pathological Transdifferentiation of Lung Epithelial Progenitors into CD66c+ Basal Cells in Severe Lung Injury. | Adv Sci (Weinh) | 2026 | 41944369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers